Clinical Trial Update: Impact of CRISP on Self-Efficacy, Loneliness, and Depression [NA]

View source ↗

Summary

A completed clinical trial evaluating the CRISP program's impact on self-efficacy, loneliness, and depression in people with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: NYU Langone Health | Conditions: Multiple Sclerosis | NA | Status: COMPLETED